This inventor holds 59 USPTO granted patents and 48 published patent applications, plus 15 CIPO patents and 26 EPO patents, primarily in Neurodegenerative Diseases (CPC class A61K). Top assignees: Blanchette Rockefeller Neurosciences Institute, Cognitive Research Enterprises, Inc., The United States of America as Represented by the Department of Health. Active years: 1986-2026.
Inventors with similar research interests:
Location History:
- Falmouth, MA (US) (1986)
- Bethesda, MD (US) (1992 - 2021)
- Chevy Chase, MD (US) (2015 - 2024)
Company Filing History:
21 out of 21 
8 out of 8 
7 out of 1,217 
Years Active: 1986-2026
Areas of Expertise:
Title: The Innovative Journey of Daniel L. Alkon
Introduction: Daniel L. Alkon, a distinguished inventor based in Bethesda, MD (US), has made significant contributions to the field of neuroscience and brain research through his groundbreaking innovations.
Latest Patents: Daniel L. Alkon holds several patents related to neurobiology, cognitive science, and medical technology, showcasing his continuous commitment to advancing scientific knowledge and improving healthcare practices.
Career Highlights: With a career spanning several decades, Daniel L. Alkon has held key positions in renowned research institutions and universities, where he has led pioneering studies on memory, learning, and brain function. His work has been instrumental in shaping our understanding of the human brain.
Collaborations: Throughout his career, Daniel L. Alkon has collaborated with leading scientists, researchers, and medical professionals from around the world, fostering a culture of innovation and knowledge exchange in the scientific community.
Conclusion: Daniel L. Alkon's passion for innovation and his relentless pursuit of scientific excellence have established him as a prominent figure in the field of neuroscience. His work continues to inspire future generations of inventors and researchers to push the boundaries of knowledge and discovery.